Acute Onset Psychiatric Diseases After SARS-CoV-2 Virus Infection Among Pediatric Patients

Overview

Journal Front Neurol

Specialty Neurology

Date 2024 Oct 24

PMID 39445192

Authors

Lu Yang

Jun Li

Dongqing Zhang

Affiliations

Soon will be listed here.

Abstract

Background: Psychiatric symptoms directly associated with SARS-CoV-2 virus infection have been reported sporadically in children. More cases of new-onset psychosis without severe cardinal symptoms, altered consciousness level, and psychogenic drug usage would offer compelling grounds for the association between the virus infection and psychosis.

Methods: We collected the clinical data of pediatric patients with new onset psychiatric symptoms after the SARS-CoV-2 virus infection from December 2022 to Feb 2023 and followed up with them for 1 year. These children did not have severe respiratory, cardiovascular, or systemic symptoms. They were not given psychogenic drugs. We also searched Pubmed to identify previously reported acute onset psychiatric cases related to SARS-CoV-2 virus infection in children. We summarized these patients' clinical symptoms, laboratory examination, treatment, and prognosis.

Results: We reported 11 new cases of psychiatric disease directly related to SARS-CoV-2 virus infection and reviewed 12 previously reported cases among children and adolescents. They had various psychiatric symptoms within 3 weeks after the virus infection. Brain MRI and EEG recording did not reveal remarkable abnormalities. The cerebrospinal fluid analysis (CSF) could find increased protein, immunoglobulin, and IL-8 levels, disrupted blood-brain barrier, and positive oligoclonal band in a minority of the patients. Most of the patients had good outcomes.

Conclusion: New-onset psychiatric symptoms directly related to SARS-CoV-2 virus infection are not rare phenomena among pediatric patients. CSF tests support the presence of central immune responses in some patients. Although these patients received different treatments, most of them had good prognoses.

References

Barthorpe A, Rogers J . Coronavirus infections from 2002 to 2021: neuropsychiatric manifestations. Sleep Med. 2022; 91:282-288. PMC: 8651478. DOI: 10.1016/j.sleep.2021.11.013. View

Tsai S . Role of interleukin 8 in depression and other psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2020; 106:110173. DOI: 10.1016/j.pnpbp.2020.110173. View

Javed S, Shad M . COVID-Related Psychosis in Adolescents: A Case-Based Review. Prim Care Companion CNS Disord. 2021; 23(6). DOI: 10.4088/PCC.21nr03107. View

Lima M, Siokas V, Aloizou A, Liampas I, Mentis A, Tsouris Z . Unraveling the Possible Routes of SARS-COV-2 Invasion into the Central Nervous System. Curr Treat Options Neurol. 2020; 22(11):37. PMC: 7515807. DOI: 10.1007/s11940-020-00647-z. View

Rose N . Negative selection, epitope mimicry and autoimmunity. Curr Opin Immunol. 2017; 49:51-55. DOI: 10.1016/j.coi.2017.08.014. View

Kepinska A, Iyegbe C, Vernon A, Yolken R, Murray R, Pollak T . Schizophrenia and Influenza at the Centenary of the 1918-1919 Spanish Influenza Pandemic: Mechanisms of Psychosis Risk. Front Psychiatry. 2020; 11:72. PMC: 7054463. DOI: 10.3389/fpsyt.2020.00072. View

Kulaga S, Miller C . Viral respiratory infections and psychosis: A review of the literature and the implications of COVID-19. Neurosci Biobehav Rev. 2021; 127:520-530. PMC: 9616688. DOI: 10.1016/j.neubiorev.2021.05.008. View

Jang H, Leem A, Chung K, Ahn J, Jung J, Kang Y . Soluble IL-2R Levels Predict in-Hospital Mortality in COVID-19 Patients with Respiratory Failure. J Clin Med. 2021; 10(18). PMC: 8471426. DOI: 10.3390/jcm10184242. View

Smith C, Gilbert E, Riordan P, Helmke N, von Isenburg M, Kincaid B . COVID-19-associated psychosis: A systematic review of case reports. Gen Hosp Psychiatry. 2021; 73:84-100. PMC: 8546431. DOI: 10.1016/j.genhosppsych.2021.10.003. View

10.

Ferrando S, Klepacz L, Lynch S, Tavakkoli M, Dornbush R, Baharani R . COVID-19 Psychosis: A Potential New Neuropsychiatric Condition Triggered by Novel Coronavirus Infection and the Inflammatory Response?. Psychosomatics. 2020; 61(5):551-555. PMC: 7236749. DOI: 10.1016/j.psym.2020.05.012. View

11.

. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet. 2021; 398(10312):1700-1712. PMC: 8500697. DOI: 10.1016/S0140-6736(21)02143-7. View

12.

Bashir Z, Butt I, Vemuri M, Geberhiwot T . Acute SARS-CoV-2-induced Psychosis in an Adolescent. Pediatrics. 2022; 150(3). DOI: 10.1542/peds.2021-056004. View

13.

Burks S, Rosas-Hernandez H, Alejandro Ramirez-Lee M, Cuevas E, Talpos J . Can SARS-CoV-2 infect the central nervous system via the olfactory bulb or the blood-brain barrier?. Brain Behav Immun. 2021; 95:7-14. PMC: 7836942. DOI: 10.1016/j.bbi.2020.12.031. View

14.

Thomas R, Hernandez M, Thomas R . Psychosis After Infection With SARS-CoV-2 in an Adolescent: A Case Report. J Am Acad Child Adolesc Psychiatry. 2022; 61(7):844-847. PMC: 8904030. DOI: 10.1016/j.jaac.2022.03.004. View

15.

Kalchev Y, Argirova P, Boev I, Yaneva A, Vatev N, Stoycheva M . Cytokine profile in patients with acute bacterial meningitis. Cytokine. 2023; 170:156315. DOI: 10.1016/j.cyto.2023.156315. View

16.

Desforges M, Le Coupanec A, Dubeau P, Bourgouin A, Lajoie L, Dube M . Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?. Viruses. 2019; 12(1). PMC: 7020001. DOI: 10.3390/v12010014. View

17.

Pavone P, Ceccarelli M, Marino S, Caruso D, Falsaperla R, Berretta M . SARS-CoV-2 related paediatric acute-onset neuropsychiatric syndrome. Lancet Child Adolesc Health. 2021; 5(6):e19-e21. PMC: 8096321. DOI: 10.1016/S2352-4642(21)00135-8. View

18.

Dantzer R . Neuroimmune Interactions: From the Brain to the Immune System and Vice Versa. Physiol Rev. 2018; 98(1):477-504. PMC: 5866360. DOI: 10.1152/physrev.00039.2016. View

19.

Jeong G, Lyu J, Kim K, Chung Y, Yoon G, Lee S . SARS-CoV-2 Infection of Microglia Elicits Proinflammatory Activation and Apoptotic Cell Death. Microbiol Spectr. 2022; 10(3):e0109122. PMC: 9241873. DOI: 10.1128/spectrum.01091-22. View

20.

Rogers J, Chesney E, Oliver D, Pollak T, McGuire P, Fusar-Poli P . Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020; 7(7):611-627. PMC: 7234781. DOI: 10.1016/S2215-0366(20)30203-0. View